CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND VINCRISTINE (CAV) FOR RELAPSE IN SMALL-CELL LUNG-CANCER (SCLC) IN PATIENTS TREATED INITIALLY WITH VP-16 AND CISPLATIN (VPP)

被引：0
|
作者：
MACCORMICK, R [1 ]
SHEPHERD, FA [1 ]
EVANS, WK [1 ]
FELD, R [1 ]
YAU, J [1 ]
机构：
[1] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1986年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [31] CISPLATIN, EPIRUBICIN AND VP 16-213 (CEV) AS INDUCTION REGIMEN IN SMALL-CELL LUNG-CANCER (SCLC)
    SCAGLIOTTI, GV
    GOZZELINO, F
    DAPUZZO, C
    ALBERA, C
    BARDESSONO, F
    PESCETTI, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A148 - A148
  • [32] EFFICACY OF CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE WITH CISPLATIN AND ETOPOSIDE IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    EICH, F
    SYBRECHT, GW
    ATEMWEGS-UND LUNGENKRANKHEITEN, 1990, 16 (09) : 407 - 408
  • [33] Second-line chemotherapy with cyclophosphamide, doxorubicin and vincristine (CAV) in patients with small cell lung cancer (SCLC) initially treated with platinum and etoposide.
    Moreau, S
    Labrune, S
    Gozy, M
    Giraud, V
    Le Guillou, F
    Blivet, S
    Chinet, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [34] TREATMENT OF NON-SMALL CELL LUNG-CANCER WITH CISPLATIN, VP-16, AND MYTOMICIN
    ARRAZTOA, J
    ORLANDI, L
    RODRIGUEZ, R
    VOGEL, C
    RAMIREZ, G
    REVISTA MEDICA DE CHILE, 1987, 115 (01) : 31 - 36
  • [35] THE ROLE OF VP-16 IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - STUDIES OF THE WEST OF SCOTLAND LUNG-CANCER GROUP
    BANHAM, S
    DORWARD, A
    HUTCHEON, A
    AHMEDZAI, S
    CUNNINGHAM, D
    BURNETT, A
    SOUKOP, M
    LUCIE, N
    KAYE, S
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 2 - 6
  • [36] VP-16 VS POLYCHEMOTHERAPY IN SMALL CELL LUNG-CANCER
    EAGAN, RT
    FRYTAK, S
    RUBIN, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 243 - 243
  • [37] CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
    VERONESI, A
    CARTEI, G
    CRIVELLARI, D
    MAGRI, MD
    DELLAVALENTINA, M
    FOLADORE, S
    TROVO, MG
    NASCIMBEN, O
    SIBAU, A
    TALAMINI, R
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1474 - 1478
  • [38] CHEMOTHERAPY WITH CISPLATINUM (CDDP) AND VP-16-213 IN SMALL-CELL LUNG-CANCER (SCLC)
    IYER, PR
    MORAN, EM
    KANESHIRO, CA
    CHEN, JJ
    OTTENHEIMER, EJ
    CLINICAL RESEARCH, 1987, 35 (03): : A524 - A524
  • [39] ETOPOSIDE (VP-16) AND CYTOSINE-ARABINOSIDE IN THE TREATMENT OF RELAPSED SMALL-CELL LUNG-CANCER
    MARGOLIN, K
    AKMAN, S
    CARR, B
    LEONG, L
    DOROSHOW, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 499 - 501
  • [40] ALTERNATING CHEMOTHERAPY WITH OR WITHOUT VP-16 IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    EVERSON, LK
    JETT, JR
    OFALLON, JR
    KROOK, JE
    DALTON, RJ
    MAILLIARD, JA
    TSCHETTER, LK
    CULLINAN, SA
    GERSTNER, JB
    MORTON, RF
    LAURIE, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (04): : 339 - 344
12345